Breaking news

Crypto.com Leverages AI Revolution With Strategic Workforce Restructuring

AI Adoption Drives Strategic Restructuring

Crypto.com reduced its workforce by 12% as part of a shift to integrate artificial intelligence across its operations. CEO Kris Marszalek said in a post on X that companies not adopting AI risk falling behind. The company removed roles that do not align with its AI-focused operating model as part of the restructuring.

Preparing For Continued Success

Reorganization aims to adjust operations to new technology requirements. The company said a smaller team supported by AI tools is expected to improve efficiency and support product development. A spokesperson confirmed affected employees have been notified.

Industry-Wide Implications

The move reflects broader trends across the technology sector, where companies are restructuring operations in response to AI adoption. Block recently announced layoffs affecting a significant share of its workforce, with CEO Jack Dorsey citing increased use of automation tools. Companies, including Meta and Atlassian, have also reduced headcount while reallocating resources toward AI and enterprise products.

High-Value Investments In AI

Crypto.com has also invested in AI-related assets. Earlier this year, Marszalek acquired the domain AI.com for $70 million, reflecting a focus on AI-related branding and positioning.

A New Paradigm For The Tech Sector

AI adoption is driving changes in how technology companies structure operations. Workforce reductions across the sector, including Meta’s anticipated 20% cut and Atlassian’s 10% reduction, reflect a shift toward efficiency and increased use of automation.

Crypto.com’s restructuring and recent investments illustrate how financial technology companies are adapting to AI integration. Changes across the sector indicate a move toward leaner operating models and greater reliance on AI-driven processes.

EU Records €220.5 Billion Pharmaceutical Trade Surplus In 2025

The European Union secured a historic trade surplus in medicinal and pharmaceutical products in 2025, according to a report from Eurostat. Export figures reached €366.2 billion while imports totaled €145.7 billion, leading to a surplus of €220.5 billion.

Robust Growth In Exports And Imports

Exports increased by 16.0% from €315.7 billion in 2024. Imports rose by 21.0% from €120.4 billion over the same period. The data show continued expansion in trade volumes across the sector.

Leading National Performances

Ireland recorded the highest exports to non-EU countries at €93.8 billion. Germany and Belgium followed with €67.9 billion and €38.5 billion, respectively. Italy led imports at €27.5 billion, with Belgium and Germany also recording significant volumes.

Global Trade Partnerships

The United States was the largest destination for EU exports, accounting for 43.8% or €160.6 billion. Switzerland followed with 16.3% (€59.7 billion), while the United Kingdom accounted for 5.6% (€20.6 billion). On the import side, the United States supplied 41.2% of total imports (€60.1 billion), followed by Switzerland at 28.4% (€41.4 billion) and China at 9.0% (€13.1 billion).

Aretilaw firm
The Future Forbes Realty Global Properties
eCredo
Uol

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter